• HIGHLIGHTS
============

\- Alpha1-adrenoceptor antagonists changed the amplitude of miniature excitatory postsynaptic currents in a subset of substantia gelatinosa neurons by slice patch-clamp technique in rat spinal cord.

\- The magnitude of the changes ranked (in descending order) from naftopidil to tamsulosin to silodosin.

INTRODUCTION
============

Lower urinary tract symptoms (LUTS) consist of voiding, storage, and postmicturition symptoms \[[@b1-inj-1938250-125]\]. Male LUTS is related to a variety of causes, including, for example, benign prostatic obstruction/benign prostatic hyperplasia, bladder dysfunction including overactive bladder, and nocturnal polyuria \[[@b2-inj-1938250-125]\]. The prevalence of LUTS increases with age, and a considerable proportion of men are affected by LUTS \[[@b3-inj-1938250-125]\]. To manage male LUTS pharmacologically, α1-adrenoceptor antagonists, 5α-reductase inhibitors, phosphodiesterase 5 inhibitors, and plant extracts are prescribed. Among these treatments, α1-adrenoceptor blockers are the most established drugs and are widely prescribed and taken. α1-adrenoceptor antagonists act by relaxing smooth muscle in the urethra and prostate, resulting in a reduction of enhanced tonus or contractility, thus counteracting decreased urine flow rates \[[@b4-inj-1938250-125]\]. Additionally, α1-adrenoceptors contribute to the improvement of storage symptoms \[[@b5-inj-1938250-125]\], although the mechanism of action of these effects remains unclear. In rats subjected to conscious cystometry, tamsulosin, naftopidil, and silodosin were shown to prolong the micturition interval \[[@b6-inj-1938250-125]\]. When isovolumetric cystometry was conducted in anesthetized animals, intrathecally administered naftopidil yielded increased inter-contraction intervals \[[@b7-inj-1938250-125]\]. Interestingly, the effect of naftopidil was counteracted by bicuculline and/or glycine injected intrathecally \[[@b8-inj-1938250-125]\]. Clinical studies have yielded contradictory results in comparisons between naftopidil and tamsulosin with evaluation by the International Prostate Symptom Score \[[@b9-inj-1938250-125]\] and by urodynamic parameters \[[@b10-inj-1938250-125]\]. The differences between the 2 studies were thought to reflect some aspect of the mode of action (e.g., a selectivity for subtypes of α1-adrenoceptors), but the actual basis of these differences remains unknown.

By using voltage-clamp recordings, it is possible to identify primary afferent information in substantia gelatinosa (SG, lamina II of Rexed) neurons \[[@b11-inj-1938250-125]\], effects that are mediated by different primary afferent fibers \[[@b12-inj-1938250-125],[@b13-inj-1938250-125]\]. The efficacy of synaptic transmission is determined by presynaptic neurotransmitter release probability and postsynaptic responsiveness, parameters that are evaluated by the frequency and amplitude of miniature excitatory or inhibitory postsynaptic currents (mEPSC or mIPSC), respectively. A slice patch-clamp recording can measure miniature excitatory and inhibitory postsynaptic currents, which are thought to reflect the following details. The frequency of the current indicates presynaptic events, which correspond to changes in the probability of neurotransmitter release and changes in the number of synapses \[[@b14-inj-1938250-125]\]. Meanwhile, the amplitude of the current indicates postsynaptic information, corresponding to changes in the number of receptors for neurotransmitters on the postsynaptic site. When outward/inward currents are observed, the recording neuron shows depolarization or hyperpolarization by activation of receptors for neurotransmitters at postsynaptic sites, yielding changes in membrane potential \[[@b15-inj-1938250-125]\]. Analyses of frequency and amplitude distributions of mEPSCs permit determination of the loci of experimental manipulation (i.e., presynaptic and/or postsynaptic) \[[@b16-inj-1938250-125]\]. The effects of naftopidil, tamsulosin, and silodosin on the frequency of excitatory synaptic currents at synaptic terminal sites in the spinal cord have been determined \[[@b17-inj-1938250-125]\], and an explanation for the diversity of efficacy in treatment of storage symptoms by α1-adrenoceptor antagonists is being developed. Naftopidil inhibits the amplitudes of EPSCs evoked by dorsal root stimulation and increases the frequencies of mEPSCs \[[@b18-inj-1938250-125]\]. However, the effect of naftopidil on the amplitudes of mEPSCs, meaning upregulation of sensitivity for depolarization of postsynaptic cells, has not yet been described (to our knowledge). Therefore, the goal of the present study was to clarify the effect of naftopidil on the amplitudes of the mEPSCs in SG neurons derived from lumbosacral spinal cord in rats and to explain the mechanism of action of α1-adrenoceptor antagonists in the treatment of storage symptoms.

MATERIALS AND METHODS
=====================

Spinal Cord Slice Preparation
-----------------------------

The methods for obtaining slices of the adult rat spinal cord and for blind patch-clamp recordings from SG neurons have been described in detail elsewhere \[[@b17-inj-1938250-125],[@b19-inj-1938250-125]\]. Briefly, adult male SpragueDawley rats (6--8 weeks old) were deeply anesthetized with urethane (1.2 g/kg, intraperitoneally), and a lumbosacral laminectomy then was performed. The lumbosacral segments of the spinal cord (L2--S3), with the associated ventral and dorsal roots, were removed and placed in ice-cold Krebs solution equilibrated with 95% O~2~--5% CO~2~. The Krebs solution contained (in mM): NaCl 117, KCl 3.6, CaCl~2~ 2.5, MgCl~2~ 1.2, NaH~2~PO~4~ 1.2, NaHCO~3~ 25, and glucose 11 (pH, 7.4). Immediately after removal of the spinal cord, the rats were killed by exsanguination under urethane anesthesia. The pia-arachnoid membrane was removed after cutting all of the ventral and dorsal roots. The spinal cord was mounted on a vibratome, and a 500-µm-thick transverse slice with the attached dorsal root was cut. The slice was placed on a nylon mesh in the recording chamber in a volume of 0.5-mL Krebs solution, and the slice was completely submerged in and perfused with Krebs solution saturated with 95% O~2~--5% CO~2~ at 37°C±1°C and a flow rate of 10--15 mL/min.

Whole-Cell Patch-Clamp Recordings From SG Neurons
-------------------------------------------------

The SG was easily discernible with transmitted illumination as a relatively translucent band across the dorsal horn in the transverse slice preparations ([Fig. 1](#f1-inj-1938250-125){ref-type="fig"}). Blind whole-cell voltage-clamp recordings were made from SG neurons, as previously described \[[@b17-inj-1938250-125],[@b19-inj-1938250-125]\]. The patch pipettes were filled with a solution containing potassium gluconate solution (in mM): K-gluconate 135, KCl 5, CaCl~2~ 0.5, MgCl~2~ 2, EGTA 5, HEPES 5, and ATPMg 5 (pH 7.2). The tip resistance of the patch pipettes was 6--12 MΩ. Series resistance was assessed according to the response to a 5-mV hyperpolarizing step. This value was monitored during the recording session, and data were rejected if values changed by \>15%. Signals were acquired with a patch-clamp amplifier (Axopatch 700A, Molecular Devices, Union City, CA, USA). The data were digitized with an AD/DA converter (Digidata 1321A, Molecular Devices), stored on a personal computer using a data acquisition program (Clampex, version 9.0, Molecular Devices), and analyzed using a software package (Clampfit, version 9.0, Molecular Devices) ([Fig. 1](#f1-inj-1938250-125){ref-type="fig"}). Cell recordings were obtained in voltage-clamp mode at holding potentials of -70 mV to record EPSCs \[[@b17-inj-1938250-125],[@b19-inj-1938250-125]\].

Drug Application
----------------

1-\[4-(2-methoxyphenyl) piperazinyl\]-3-(1-naphthyloxy) propan-2-ol (naftopidil) (PubChem CID: 4418) (Asahi Kasei Pharma Co., Tokyo, Japan) was dissolved in 1% dimethyl sulfoxide (DMSO) (PubChem CID: 679) (Wako, Osaka, Japan) in Krebs solution. Tamsulosin and silodosin were dissolved in Krebs solution. All drugs were applied by sequential perfusion in a single cell with washout periods via a three-way stopcock without changes in the perfusion rate or temperature. The application schedule was as described previously \[[@b17-inj-1938250-125]\].

Statistical Analysis
--------------------

Statistical analysis was performed using JMP ver. 14 (SAS Institute, Cary, NC, USA), and P-values \<0.05 were considered statistically significant. The analyses consisted of 4 sets of tests as described below.

### Correlation of the amplitudes before and after administration of each α1-adrenoceptor antagonist in the SG neurons

For individual SG neurons, the amplitude after administration of naftopidil, tamsulosin, or silodosin was plotted against amplitude before administration of the respective reagent. For each α1-adrenoceptor antagonist, correlations were subjected to linear regression, and the values of r^2^ and the slopes of the regression lines were calculated. Pearson correlation coefficients (r) were analyzed for point-estimates and 95% confidence intervals (CIs) using 2-tailed tests.

### Change of amplitude after administration of the α1-adrenoceptor antagonist

For global analysis, amplitudes after administration of all α1-adrenoceptor antagonists were compared to those before administration of the blockers by using a 2-tailed paired t-test. If the statistical significance was confirmed in the global analysis, the differences in changes of amplitude were compared between each α1-adrenoceptor antagonist in the same SG neuron, again using a 2-tailed paired t-test. Additionally, differences in the amplitudes before and after administration were compared for naftopidil, tamsulosin, and silodosin using the 2-tailed Tukey-Kramer test.

### Waterfall plot analysis for each α1-adrenoceptor blocker

To compare the extent of changes in amplitudes by naftopidil, tamsulosin, and silodosin in individual SG neurons, waterfall plots were generated for the differences in amplitudes between the before-and after-administration values for each α1-adrenoceptor antagonist. The effects of each antagonist were plotted as histograms of values in descending order of difference.

### Inward and outward current of EPSC

SG neurons that showed inward and/or outward currents in response to α1-adrenoceptor antagonist exposure were selected, and the corresponding data were used to calculate the rates of response.

RESULTS
=======

Whole-Cell Patch-Clamp Recordings From SG neurons
-------------------------------------------------

Typical mEPSC recordings of changes of amplitude in response to α1-adrenoceptor antagonist exposure are provided in [Fig. 2](#f2-inj-1938250-125){ref-type="fig"}, including examples that exhibited changes in frequency and amplitude either without inducing outward and/or inward current (A), with inward current induced (B), or with outward current induced (C).

Correlation of the Amplitudes Before and After Bath Application of Each α1-Adrenoceptor Antagonist in SG Neurons
----------------------------------------------------------------------------------------------------------------

Pearson correlation coefficients for the amplitudes between the baseline and postadministration of α1-adrenoceptor antagonists ranked (in decreasing order) as naftopidil (r=0.393; 95% CI, 0.074--0.639), tamsulosin (r=0.738; 95% CI, 0.541--0.859), and silodosin (r=0.944; 95% CI, 0.891--0.971). For the correlation coefficient, the extent of lowering from 1.000 corresponds to potency of the drug. For naftopidil, tamsulosin, and silodosin, the regression lines yielded values for slopes of 0.573, 1.046, and 1.143, respectively ([Fig. 3](#f3-inj-1938250-125){ref-type="fig"}).

Change of Amplitude After Administration of α1-Adrenoceptor Antagonists
-----------------------------------------------------------------------

Global analysis showed that the α1-adrenoceptor antagonists yielded significant increases in the amplitude of mEPSCs of SG neurons, which rose from 11.8 pA at baseline to 13.0 pA following exposure (n=108, P=0.012) ([Table 1](#t1-inj-1938250-125){ref-type="table"}). However, only silodosin demonstrated a significant elevation (relative to the baseline) when the data were broken down by antagonist (n= 36 each) from 11.7 pA to 12.5 pA (P=0.005). Naftopidil and tamsulosin tended to increase the amplitudes but without statistical significance with individual effects as follows: naftopidil, from 12.1 pA to 13.9 pA (P=0.129); tamsulosin, from 11.7 pA to 12.5 pA (P=0.201) ([Table 1](#t1-inj-1938250-125){ref-type="table"}). Additionally, statistical significances were not found among α1-adrenoceptor antagonists for the changes of amplitude before and after application of the antagonists to a given SG neuron ([Table 1](#t1-inj-1938250-125){ref-type="table"}).

Waterfall Plot Analysis for Each α1-Adrenoceptor Antagonist
-----------------------------------------------------------

As shown in [Fig. 4](#f4-inj-1938250-125){ref-type="fig"}, the waterfalls plots of naftopidil, tamsulosin, and silodosin permitted apparent ranking by the strength of the effects. The changes of amplitudes of mEPSCs for naftopidil ranged from positive to negative, while those for silodosin exhibited a narrower range.

Inward and Outward Current of EPSCs
-----------------------------------

Observability of inward or outward current following α1-adrenoceptor antagonist exposure differed among naftopidil (total: 9 out of 36 cells, 25.0%; inward: 3 cells, 8.3%; outward: 6 cells, 16.7%), tamsulosin (total: 5 out of 36 cells, 13.9%; outward only), and silodosin (total: 2 out of 36 cells, 5.6%; outward only). The values of the currents are summarized in [Table 2](#t2-inj-1938250-125){ref-type="table"}.

DISCUSSION
==========

In individual SG neurons, each of 3 α1-adrenoceptor antagonists was evaluated sequentially with mEPSC recording by the patch-clamp technique. The amplitudes of the mEPSCs were analyzed and the descriptive statistics values were noted. Various types of responsiveness to each α1-adrenoceptor antagonists were observed ([Fig. 4](#f4-inj-1938250-125){ref-type="fig"}). The responsiveness to naftopidil was twice that to tamsulosin (25% vs. 13.9%), and 5 times that to silodosin (25% vs. 5.6%), as shown in [Table 2](#t2-inj-1938250-125){ref-type="table"}.

Correlation of the Amplitude of mEPSCs Between Baseline and After Application of Each α1-Adrenoceptor Antagonist
----------------------------------------------------------------------------------------------------------------

For tamsulosin and silodosin, Pearson correlation coefficients for the amplitudes between baseline and after the application were 0.738 and 0.944 (respectively), implying strong correlation. In contrast, the value for naftopidil was 0.393, suggesting weak correlation. These results indicated that the changes of amplitude of mEPSCs between before and after the application of α1-adrenoceptor antagonists are small for tamsulosin or silodosin and large for naftopidil. Furthermore, since a change in the amplitude of mEPSCs reveals a change in sensitivity for postsynaptic excitation (e.g., an upregulation of receptors for glutamate), naftopidil may promote changes in sensitivity, an effect not seen with tamsulosin and silodosin.

Responsiveness of the Amplitude of mEPSCs to α1-Adrenoceptor Antagonists
------------------------------------------------------------------------

Our global analysis indicated that α1-adrenoceptor antagonists increase the amplitude of the mEPSCs of SG neurons. We hypothesize that the effects of naftopidil and tamsulosin were not statistically significant because the numbers of SG neurons that responded to naftopidil or tamsulosin were low. For instance, if the responsive SG neurons are defined as those in which the amplitude (pA) of mEPSCs change by\>20% or\<-20% (relative to the baseline), then 8 would be considered responsive to naftopidil and 5 each would be considered responsive to tamsulosin or silodosin (out of 36 SG neurons each; data not shown). In terms of the differences (∆) in amplitude, the effect size was smallest in the silodosin group ([Table 1](#t1-inj-1938250-125){ref-type="table"}). Therefore, we infer that the smaller variance in the amplitude of mEPSCs was the reason that statistical significance was observed after application of silodosin. The ranges of responses observed in the amplitudes differed among the α1-adrenoceptor antagonists, as shown in the waterfall plots ([Fig. 3](#f3-inj-1938250-125){ref-type="fig"}). The waterfall plots for tamsulosin and silodosin resembled each other, which may reflect the small difference in the Pearson correlation coefficients for these 2 antagonists (0.738 and 0.944, respectively). Although the increases in the amplitude of mEPSCs with naftopidil and tamsulosin fell short of statistical significance, the responsive SG neurons (i.e., those whose amplitude (in pA) increased or decreased by more than 20% relative to the baseline) represented a subpopulation (among 36 SG neurons each) of 8 for naftopidil and 5 for tamsulosin neurons (data not shown). These results suggested that the neurons responsive to specific α1-adrenoreceptor blockers are present in defined proportions. Given that mEPSCs represent glutamatergic transmission in afferent fibers \[[@b20-inj-1938250-125]\], increases in the amplitude of mEPSCs suggest upregulation of the sensitivity of receptors that mediate glutamatergic transmission, which in turn would be expected to facilitate inhibitory GABAergic and/or glycinergic interneurons. Although silodosin exposure yielded a significant increase in the amplitude of mEPSCs ([Table 1](#t1-inj-1938250-125){ref-type="table"}), the magnitude of the effect was small. Therefore, silodosin may have a limited effect on SG neurons.

Previous work showed that naftopidil suppresses the amplitude of mEPSCs evoked by dorsal root stimulation in the SG neurons of slices isolated from the lumbosacral spine, while prazosin does not \[[@b21-inj-1938250-125]\]. Those results indicated that naftopidil may attenuate the excitation caused by primary afferent fibers at the postsynaptic site without blocking α1-adrenoceptors. Furthermore, naftopidil facilitated larger changes in the frequencies of mEPSCs in SG neurons of slices isolated from the same level of spine than did tamsulosin or silodosin \[[@b17-inj-1938250-125]\]. This distinction suggests that naftopidil's ability to suppress the micturition reflex may result from excitation of postsynaptic cells via an elevated frequency of neurotransmitter release from the presynaptic sites, facilitating inhibition in subsequent inhibitory interneurons. The present study indicated that naftopidil increased and decreased the amplitude of the mEPSCs in SG neurons ([Fig. 4](#f4-inj-1938250-125){ref-type="fig"}). The increases suggest upregulation of the sensitivity at the postsynaptic site for the neurotransmitter (e.g., GABA, glycine) released from the presynaptic terminal. The decreases suggest downregulation of the sensitivity at the postsynaptic site for the neurotransmitter (e.g., glutamate) released from the presynaptic terminal. These bidirectional effects suggest that increases and decreases in amplitude may reflect the excitation and sedation (respectively) of postsynaptic cells.

In the present study, the α1-adrenoceptor antagonists generated inward or outward currents in a subset of SG neurons; notably, the outward current was observed more readily than was the inward current ([Table 2](#t2-inj-1938250-125){ref-type="table"}). We speculate that the 3 antagonists directly facilitate hyperpolarization of SG neurons by generating outward currents. In view of the inward current seen for mEPSCs, it is possible that naftopidil encourages depolarization in a small subpopulation of the SG neurons. These results suggest that naftopidil modulates neurotransmission in the SG neurons multimodally.

Extrapolation of Changes in mEPSCs to Effects on Micturition
------------------------------------------------------------

It remains difficult, using the current technique, to determine an actual relationship between the amplitude of EPSC and the storage symptoms. At minimum, *in vivo* electrophysiological recording would need to be combined with cystometry, which would have to be performed under anesthesia. As far as we know, correlations between urinary bladder activity and afferent nerve activity, but not between bladder activity and EPSC, have been reported, in which action potentials of afferent fibers isolated from the left L6 dorsal root were recorded \[[@b22-inj-1938250-125]\]. In the previous study on EPSC, a correlation between the amplitude and the afferent nociceptive input was reported \[[@b19-inj-1938250-125]\]. There is a substantial difference between painful stimuli and storage symptoms, but both are aspects of the afferent sensory nerve. Therefore, we speculate that the amplitude of EPSC may modulate the storage symptoms.

During the storage of urine, the storage reflex generated by primary afferent firing is coordinated by the spinal reflex pathway \[[@b23-inj-1938250-125]\]. In human functional analysis, bladder activity is mediated by stimulation of brain subregions (for example, the periaqueductal gray matter \[[@b24-inj-1938250-125]\]). In the lumbosacral region, the SG (lamina II) of the spinal dorsal horn contains a high density of excitatory and inhibitory interneurons that are thought to be critically involved in the modulation of nociception \[[@b25-inj-1938250-125]\] and (presumably) the micturition reflex. Sensory information is carried from the pelvic organs to the dorsal horn of the lumbosacral spinal cord \[[@b26-inj-1938250-125]\]. In the rat spinal cord, glutamatergic mechanisms play an essential role in micturition control \[[@b27-inj-1938250-125]\]. Intrathecal injection of α1-adrenoceptor antagonists has been shown to inhibit the micturition reflex in animal models \[[@b7-inj-1938250-125],[@b28-inj-1938250-125]\]. These results suggest that the α1-adrenoceptor antagonists exert their activity at the spinal level in the neural circuitry. In the present study, several neurons exhibited increased or decreased amplitudes of mEPSCs in response to α1-adrenoceptor antagonists, particularly naftopidil ([Fig. 4](#f4-inj-1938250-125){ref-type="fig"}). These results indicated that the postsynaptic sites of various SG neurons have differing sensitivities for excitatory neurotransmitters (e.g., glutamate). Although the physiological significance of the amplitude of the EPSC has not been determined to date, the 3 α1-adrenoceptor antagonists tested in the present study are presumed to exert their activities in the postsynaptic site, while prazosin apparently does not \[[@b21-inj-1938250-125]\]. As shown in the waterfall plots of the present study, neurons that responded to the α1-adrenoceptor antagonists predominantly exhibited increased (and not decreased) amplitudes of mEPSCs. Therefore, we speculate that naftopidil and tamsulosin suppress micturition by upregulating sensitivity at the postsynaptic site of inhibitory interneurons, thereby activating inhibitory neurotransmission. Additionally, silodosin may contribute in part by activating the inhibitory pathway in the spinal cord.

In conclusion, although exposure to α1-adrenoceptor antagonists increased the amplitudes of mEPSCs in rat SG neurons in slices prepared from the L6--S1 spine level, these effects reflected responses in a subset of the SG neurons. Additionally, the α1-adrenoceptor antagonists generated inward/outward currents in the SG neurons. The magnitude of the changes induced by the α1-adrenoceptor antagonists ranged (in descending order) from naftopidil to tamsulosin to silodosin. These results are expected to increase our understanding of the mechanisms of action (at the spine level) of α1-adrenoceptor antagonists when used clinically for the treatment of storage symptoms associated with LUTS.

This study is phenomenologically based; therefore, further electrophysiological and molecular biological investigations of the proposed mechanisms will be needed. Although afferent nerves from the urothelium largely project to lamina X in the dorsal horn, SG neurons in lamina II were used. As described previously, a part of the superficial neurons receives nociceptive and non-nociceptive inputs from the lower urinary tract, as shown by upregulation of cFos expression \[[@b29-inj-1938250-125]\]. Although the use of lamina X would be ideal, that structure possesses a low density of neurons, making the blind attachment of patchclamp electrodes less efficient. Therefore, lamina II was examined. Furthermore, our results indicated that α1-adrenoceptor antagonists alter the amplitudes of mEPSCs in only a subset of SG neurons. This observation is consistent with the existence of multiple types of SG neurons within this lumbosacral level \[[@b30-inj-1938250-125]\].
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![The experimental method and design are illustrated. Blind whole-cell patch-clamp recording was performed in individual substantia gelatinosa neurons of an adult rat spinal dorsal horn. A/D, analog to digital.](inj-1938250-125f1){#f1-inj-1938250-125}

![Charts of typical mEPSCs are presented. (A) Frequency and amplitude were changed but outward/inward currents were not altered. (B, C) Inward current and outward currents (respectively) were observed. The bar indicates the time of application of the α1-adrenoceptor blocker.](inj-1938250-125f2){#f2-inj-1938250-125}

![Correlations of the amplitudes of mEPSCs between baseline and postadministration of α1-adrenoceptor antagonists. n=36. mEPSC, miniature excitatory postsynaptic current.](inj-1938250-125f3){#f3-inj-1938250-125}

![Waterfall plots for the difference of amplitudes of mEPSCs between baseline and postadministration of α1-adrenoceptor antagonists. The values of the differences were aligned in descending order. n=36. mEPSC, miniature excitatory postsynaptic current.](inj-1938250-125f4){#f4-inj-1938250-125}

###### 

The effects of α1-adrenoceptor antagonists on the amplitude of EPSC in SG neurons of slices prepared from the lumbosacral level in rats

  α1-adrenoceptors      Amplitude of EPSC, pA     P-values                                                    
  --------------------- ------------------------- ------------------------- ------------------------- ------- -----------------------
  Global (n = 108)      11.8 ± 4.1 (11.1--12.6)   13.0 ± 5.7 (11.9--14.0)   1.1 ± 4.5 (0.3--2.0)      0.012   \-
  Naftopidil (n = 36)   12.1 ± 4.9 (10.5--13.8)   13.9 ± 7.1 (11.5--16.3)   1.8 ± 6.9 (-0.5 to 4.1)   0.129   0.226, vs. tamsulosin
                                                                                                              0.377, vs. silodosin
  Tamsulosin (n = 36)   11.7 ± 3.6 (10.5--12.9)   12.5 ± 5.0 (10.8--14.2)   0.7 ± 3.4 (-0.4 to 1.9)   0.201   0.914, vs. silodosin
  Silodosin (n = 36)    11.7 ± 3.8 (10.4--12.9)   12.5 ± 4.6 (10.9--14.0)   0.8 ± 1.6 (0.3--1.4)      0.005   \-

Values are presented as means±standard error of the mean with 95% confidence interval in parentheses.

Statistical analyses were performed by 2-tailed paired Student *t*-tests to compare the values between baseline and after treatment in a given neuron, and by 2-tailed Turkey-Kramer test to compare the values among the groups treated with distinct α1-adrenoceptor antagonists.

EPSC, excitatory post synaptic current; SG, substantia gelatinosa.

###### 

The values of inward/outward currents generated by each α1-adrenoceptor antagonist

  ID        Naftopidil (pA)   Tamsulosin (pA)   Silodosin (pA)                      
  --------- ----------------- ----------------- ---------------- ---------- ------- ---------
  1         0                 29.42             0                7.99       0       10.44
  7         5.63              0                 0                0          0       0
  8         0                 15.94             0                6.66       0       0
  9         0                 9.61              0                6.18       0       0
  10        0                 10.24             0                8.12       0       7.34
  12        0                 10.74             0                2.22       0       0
  13        12.65             0                 0                0          0       0
  19        0                 16.46             0                0          0       0
  21        10.20             0                 0                0          0       0
  No. (%)   3 (8.3)           6 (16.7)          0 (0)            5 (13.9)   0 (0)   2 (5.6)

[^1]: Daisuke Uta and Tsuyoshi Hattori contributed equally to this study as co-first authors.
